Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119


Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels.

Zhou S, Zong Y, Ney PA, Nair G, Stewart CF, Sorrentino BP.

Blood. 2005 Mar 15;105(6):2571-6. Epub 2004 Nov 16.


Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.

Kobuchi H, Moriya K, Ogino T, Fujita H, Inoue K, Shuin T, Yasuda T, Utsumi K, Utsumi T.

PLoS One. 2012;7(11):e50082. doi: 10.1371/journal.pone.0050082. Epub 2012 Nov 26.


Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.

Ogino T, Kobuchi H, Munetomo K, Fujita H, Yamamoto M, Utsumi T, Inoue K, Shuin T, Sasaki J, Inoue M, Utsumi K.

Mol Cell Biochem. 2011 Dec;358(1-2):297-307. doi: 10.1007/s11010-011-0980-5. Epub 2011 Jul 12.


Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX.

Jonker JW, Musters S, Vlaming ML, Plösch T, Gooijert KE, Hillebrand MJ, Rosing H, Beijnen JH, Verkade HJ, Schinkel AH.

Am J Physiol Cell Physiol. 2007 Jun;292(6):C2204-12. Epub 2007 Feb 21.


ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells.

Asashima T, Hori S, Ohtsuki S, Tachikawa M, Watanabe M, Mukai C, Kitagaki S, Miyakoshi N, Terasaki T.

Pharm Res. 2006 Jun;23(6):1235-42. Epub 2006 May 25.


Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytes.

Lin YH, Chang HM, Chang FP, Shen CR, Liu CL, Mao WY, Lin CC, Lee HS, Shen CN.

FEBS Lett. 2013 Oct 1;587(19):3202-9. doi: 10.1016/j.febslet.2013.08.011. Epub 2013 Aug 14.


Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells.

Susanto J, Lin YH, Chen YN, Shen CR, Yan YT, Tsai ST, Chen CH, Shen CN.

PLoS One. 2008;3(12):e4023. doi: 10.1371/journal.pone.0004023. Epub 2008 Dec 24.


Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.

Hagiya Y, Fukuhara H, Matsumoto K, Endo Y, Nakajima M, Tanaka T, Okura I, Kurabayashi A, Furihata M, Inoue K, Shuin T, Ogura S.

Photodiagnosis Photodyn Ther. 2013 Sep;10(3):288-95. doi: 10.1016/j.pdpdt.2013.02.001. Epub 2013 Mar 15.


Constitutive expression of the ATP-binding cassette transporter ABCG2 enhances the growth potential of early human hematopoietic progenitors.

Ahmed F, Arseni N, Glimm H, Hiddemann W, Buske C, Feuring-Buske M.

Stem Cells. 2008 Mar;26(3):810-8. Epub 2007 Nov 29.


Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.

Hagiya Y, Endo Y, Yonemura Y, Takahashi K, Ishizuka M, Abe F, Tanaka T, Okura I, Nakajima M, Ishikawa T, Ogura S.

Photodiagnosis Photodyn Ther. 2012 Sep;9(3):204-14. doi: 10.1016/j.pdpdt.2011.12.004. Epub 2012 Jan 4.


Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.

Delaby C, Lyoumi S, Ducamp S, Martin-Schmitt C, Gouya L, Deybach JC, Beaumont C, Puy H.

Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):45-52.


ABCG2 membrane transporter in mature human erythrocytes is exclusively homodimer.

Leimanis ML, Georges E.

Biochem Biophys Res Commun. 2007 Mar 9;354(2):345-50. Epub 2007 Jan 9.


Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.

Yamamoto M, Fujita H, Katase N, Inoue K, Nagatsuka H, Utsumi K, Sasaki J, Ohuchi H.

Acta Med Okayama. 2013;67(3):153-64.


ABCG2 transports and transfers heme to albumin through its large extracellular loop.

Desuzinges-Mandon E, Arnaud O, Martinez L, Huché F, Di Pietro A, Falson P.

J Biol Chem. 2010 Oct 22;285(43):33123-33. doi: 10.1074/jbc.M110.139170. Epub 2010 Aug 12.


Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.

Dohse M, Scharenberg C, Shukla S, Robey RW, Volkmann T, Deeken JF, Brendel C, Ambudkar SV, Neubauer A, Bates SE.

Drug Metab Dispos. 2010 Aug;38(8):1371-80. doi: 10.1124/dmd.109.031302. Epub 2010 Apr 27.


Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.

Ishikawa T, Kajimoto Y, Inoue Y, Ikegami Y, Kuroiwa T.

Adv Cancer Res. 2015;125:197-216. doi: 10.1016/bs.acr.2014.11.008. Epub 2015 Jan 8. Review.


Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.

Barron GA, Moseley H, Woods JA.

J Photochem Photobiol B. 2013 Sep 5;126:87-96. doi: 10.1016/j.jphotobiol.2013.07.003. Epub 2013 Jul 10.


Erythroblasts highly express the ABC transporter Bcrp1/ABCG2 but do not show the side population (SP) phenotype.

Yamamoto K, Suzu S, Yoshidomi Y, Hiyoshi M, Harada H, Okada S.

Immunol Lett. 2007 Nov 30;114(1):52-8. Epub 2007 Sep 17.


Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells.

Pfister O, Oikonomopoulos A, Sereti KI, Sohn RL, Cullen D, Fine GC, Mouquet F, Westerman K, Liao R.

Circ Res. 2008 Oct 10;103(8):825-35. doi: 10.1161/CIRCRESAHA.108.174615. Epub 2008 Sep 11.


The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.

Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K.

Clin Cancer Res. 2002 Jan;8(1):22-8.

Supplemental Content

Support Center